BTL Announces Expanded Clearances and Versatility for EMSELLA® Platform
FDA-cleared and Health Canada-licensed for the treatment of urinary incontinence in both men and women, Emsella now also holds an additional Health Canada license and CE-mark certification for enhancing sexual function in patients experiencing somatic sexual arousal disorders caused by weak pelvic floor muscles.
Backed by robust clinical outcomes, EMSELLA continues to redefine non-invasive care across pelvic health and sexual function. Key findings include:
Sexual Dysfunction Statistics:
76% improvement in sexual satisfaction and desire 1
60% improvement in orgasm quality 1
37% improvement in maintaining erection during intercourse 2
48% improvement in pelvic muscle endurance 3
When compared to other modalities, EMSELLA outperforms significantly:
7x more effective than pelvic floor muscle training
"EMSELLA continues to surpass expectations—not just in treating incontinence but in restoring confidence, and overall quality of life," said David Chmel, CEO of BTL North America. "These expanded clearances and clinical outcomes validate what providers and patients have long experienced: EMSELLA delivers meaningful results in a way that's accessible, comfortable, and non-invasive."
Shari Caplan, MD, CCFP, FCFP, FAARM, a board-certified expert in functional, integrative , anti-aging, and intimate health said, "We're witnessing a complete shift in how pelvic and sexual health is approached. Patients are achieving results we used to think were only possible with surgery or years of therapy. EMSELLA has become a go-to solution in my practice for urinary control and sexual wellness for both men and women."
As the demand for intimate wellness treatments rises, EMSELLA remains uniquely positioned as an effective and versatile tool for addressing some of the most intimate and often under-discussed health concerns.
To learn more about EMSELLA, visit www.emsella.com.
About BTL
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 350+ patents and over 580 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.
For more information, visit www.bodybybtl.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
14 hours ago
- Winnipeg Free Press
Pharmacists reject tobacco giant's argument for more retail access to nicotine pouches
Canada's largest tobacco company is ratcheting up efforts to rescind a federal government order last year requiring that nicotine pouches be sold behind the counter at pharmacies. Imperial Tobacco's public relations campaign says that the ministerial order has made its Zonnic nicotine-replacement therapy pouches more difficult for smokers to access. Pharmacists — 'front-line health professionals who are already time-squeezed and over-burdened' — are 'increasingly disgruntled by the new demands of this order,' it said. SUBMITTED An advertisement in a convenience store that sells Zonnic, a nicotine replacement product to help adults quit smoking that is not authorized to be sold to anyone under the age of 18. Users place the pouches between their upper lip and gum for up to 60 minutes, releasing nicotine that temporarily curbs cravings and nicotine withdrawal symptoms, Imperial Tobacco says on its Zonnic website. The association representing Manitoba pharmacists called that 'very, very strange.' 'There's no pharmacist being disgruntled or frustrated about the need to have people access these products in pharmacies,' said Britt Kural, pharmacy practice adviser with Pharmacists Manitoba. 'This is what we do — we do it really well.' She said pharmacists are among the most accessible health-care providers and able to help people find the right product to help them stop smoking. 'Pharmacists are experts in smoking cessation and we want to help people find the best options to help them in that journey,' Kural said Friday. The pharmacy 'is exactly the right spot' for nicotine pouches that Imperial Tobacco and the government have classified as nicotine replacement therapy (NRT). 'We appreciate being able to have them available to consider for people when they want to stop smoking,' she said. Not every pharmacist appreciates being 'the gatekeeper and policing an NRT product that has been approved by Health Canada,' said Imperial Tobacco's vice-president of corporate and regulatory affairs. Eric Gagnon said the company has heard concerns raised by pharmacy groups about it increasing their workload. 'I wouldn't say that everybody's on the same page,' he said from Montreal. 'The Neighbourhood Pharma Association has raised concern about moving (nicotine replacement therapies) behind the pharmacy counter,' said Gagnon. That could place an 'additional burden on pharmacy professionals,' he said. 'We hosted an event in Western Canada with pharmacists a few months ago, and they also raised some concerns.' When the federal order was issued last August, Zonnic could no longer be sold where smokers regularly purchase cigarettes, and the flavours were restricted to mint and menthol. At the time, Gagnon accused the federal health minister of 'singling out' Imperial Tobacco, while giving pharmaceutical companies a pass. 'All smoking cessation products should be regulated in the same way,' Gagnon said in an Aug. 22, 2024 press release. 'This is not how good public health policy is made.' When Zonnic tins — containing 24 pouches — were sold in convenience stores, there was an accelerated decline in cigarette sales, said Gagnon, adding that they've helped 'many thousands' quit smoking. Nearly a year later, moving nicotine pouches behind the counter hasn't helped those trying to quit smoking, or Canada in meeting its stated goal of attaining a smoking rate of below five per cent by 2035, he said. 'We're concerned that either people will start smoking again or, as we have seen, people will start buying illegal nicotine products which often contain a lot more than the four milligrams that has been approved by Health Canada.' He said specialty and online shops are illegally selling products that contain six, nine or even 15 milligrams of nicotine. The push to get pouches sold over the counter alongside cigarettes comes after the settlement of a class-action lawsuit by provinces including Manitoba. Big Tobacco companies — including Imperial — are to cough up billions in after-tax profits solely from tobacco sales over the next 20 years. 'They need to get as many people addicted to alternative products — which includes pouches — as possible, for survival,' said the head of the Manitoba Tobacco Reduction Alliance. Cynthia Carr predicted after the tobacco settlement was announced in March that the companies would push for easier access to highly addictive nicotine pouches to grow their customer base. 'Not only are they handing over $6 billion or so, cash in hand, to start, they then have to start providing up to 85 per cent of their after-tax profits from tobacco. So if they only have a tiny portion left, of course they're going to sell every other product they can,' said Carr, a Winnipeg epidemiologist. The federal government cracked down on the colourful packaging and flavours of nicotine pouches after studies showed youths were attracted and increasingly using them, Carr said Friday. Wednesdays What's next in arts, life and pop culture. 'The company was marketing this to that younger audience, making them fun, fancy flavours — cool designs that were really meant to appeal to a younger population,' said Kural. 'There can be some serious health consequences to underage individuals using these types of nicotine products or any nicotine product,' the pharmacist said. 'That younger population may not understand the consequences that nicotine can have on their overall health and especially in the growth stage of their health.' Kural said she doesn't think that pharmacists — or any health-care practitioner — would support returning nicotine pouches to over-the-counter sales. 'We're trying to prevent this from falling into the hands of people who shouldn't be using it,' she said. Carol SandersLegislature reporter Carol Sanders is a reporter at the Free Press legislature bureau. The former general assignment reporter and copy editor joined the paper in 1997. Read more about Carol. Every piece of reporting Carol produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
Cision Canada
19 hours ago
- Cision Canada
Public advisory - Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Français
Product: Unauthorized injectable peptide drugs Issue: Health products – Unauthorized product; Product safety What to do: Consult a healthcare professional if you have used an unauthorized injectable drug on the list below and have health concerns. Do not buy or use unauthorized drugs. Only buy prescription drugs from licensed pharmacies. Read product labels to confirm a product has been authorized for sale by Health Canada. Affected products Unauthorized injectable peptide drugs, including: • AOD9604 • ARA 290 • Bremelanotide • Bronchogen • BPC-157 • CJC-1295 • Cortagen • DSIP • Epitalon • GHK, GHK-Cu • GHRP 2 • GHRP 6 • GLP-1 (7-37) • Gonadorelin • Hexarelin • HGH, HGH Fragment • Humanine • Ipamoreline • Kisspeptin • KK-23 • Livagen • LL-37 • Melanotan 1 • Melanotan II • NR-7 • Ovagen • Pal-GHK • Pinealon • PNC-27 • Prostamax • QS-13 • Retatrutide • Selank • Semax • Sermorelin • SS-31 • Tesamorelin • Thymosin alpha • Thymosin-β4 (TB4 or TB-500) • Tirzepatide • Vilon • VIP Issue Health Canada is warning the public of seized unauthorized injectable peptide drugs from Canada Peptide. The products were being sold via the company's website. Peptide drugs affect the body's functions and are often used for bodybuilding, anti-aging, or enhancing athletic performance. Injectable peptides are regulated as prescription drugs in Canada. Health Canada has not authorized any of the products that were seized or sold on the company's website, which means that they have not been assessed for safety, efficacy, and quality. Selling unauthorized drugs is illegal in Canada. Prescription drugs should only be used under the care of a healthcare professional because they are used to treat specific conditions and may cause serious side effects. Unauthorized injectable drugs may: Cause infectionallergic reactions, and other poor outcomes. Interact with other medications an individual might be taking. Contain high-risk ingredients, additives, or contaminants that may or may not be listed on the label. Not have been manufactured or stored safely. Should additional safety concerns be identified, Health Canada will take appropriate action to protect public health and safety, including communicating updates, if needed. What you should do Consult a health care professional (physician, nurse practitioner, pharmacist) if you have used an unauthorized injectable drug and have health concerns. Follow municipal or regional guidelines on how to dispose of chemicals and other hazardous waste or return the product to your local pharmacy for proper disposal. Only buy prescription drugs from licensed pharmacies. Be aware of the risks of buying health products online. Do not buy or use unauthorized drugs. You can read product labels to confirm the product has been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database. Report any health product-related side effects or complaints to Health Canada.
Winnipeg Free Press
19 hours ago
- Winnipeg Free Press
Sunshine House mobile drug site in limbo after RV totalled
The Sunshine House drug testing and supervised consumption services, which operated out of an RV, have ground to a halt since the vehicle was totalled in a hit-and-run July 2. Sunshine House was given an ambulance by the Salvation Army, but federal regulations require it to be approved. 'We're following all the guidelines and rules around this type of service, but because we're the only service in the province that does this, there is a sense of urgency to find a solution,' executive director Levi Foy said Friday. MIKE DEAL / FREE PRESS FILES Sunshine House's RV was totalled in a hit-and-run on July 2. The Mobile Overdose Prevention Site would help, on average, 500 people per day by giving them harm-reduction supplies, supervising their drug consumption and testing their drugs on a mass spectrometer. The RV needs a federal exemption from drug laws to be operable. Supervised consumption sites require an exemption under section 56.1 of the federal Controlled Drugs and Substances Act, Health Canada says. Foy is concerned that approval could take another month; he's heard anecdotes from staff and community members that overdoses have gone up since the RV left the road. Foy said he has been told there have been negative reactions to substances being sold as meth, but without the mass spectrometer, there's no way of knowing what is causing the effects. 'We don't really have a back door option and we don't really have any other ability to deliver services,' Foy said. In July, supervised consumption site advocate Safer Sites issued a drug alert warning the public a substance tested at another location came back positive for para-fluorofentanyl, a synthetic opioid, and was connected to five overdoses. Another notice stated a substance sold as the street drug 'down' was suspected to be related to 19 emergency calls requiring the use of naloxone over a 24-hour period on July 29. A review of city data shows the Winnipeg Fire Paramedic Service responded to 249 calls where naloxone was administered 438 times, down from June's 330 calls and 612 administrations. In its most recent annual report, the mobile overdose van recorded more than 26,000 visits from Oct. 28, 2022 to Oct. 31, 2023. There were 7,086 visits to consume drugs, which resulted in 20 overdose incidents, four trips to the hospital and no deaths. Arlene Last-Kolb, co-founder of Overdose Awareness Manitoba and a member of Moms Stop the Harm, worries about what could happen to the downtown core if services are interrupted long-term. 'We know our supply is so toxic that having a safe consumption site… to me, is essential,' she said. Preliminary data from the province shows there were 570 suspected substance-related deaths in 2024. In the first two months of 2025, 81 people died owing to suspected substance-related deaths. Foy said that without the supervised consumption service, drug users can only do so nearby and staff can check on them or offer them space in the ambulance afterward. Tuesdays A weekly look at politics close to home and around the world. The gap in service underscores the urgent need for the supervised consumption site promised by the NDP government, Last-Kolb said. 'If I had a child, I'd be very worried right now,' she said. In early July, Addictions Minister Bernadette Smith said the province is 'moving toward' having a site operating in Winnipeg by year's end. Health Canada lists the Winnipeg application as being in the 'review' stage and 'awaiting key information before decision can be taken.' Nicole BuffieMultimedia producer Nicole Buffie is a reporter for the Free Press city desk. Born and bred in Winnipeg, Nicole graduated from Red River College's Creative Communications program in 2020 and worked as a reporter throughout Manitoba before joining the Free Press newsroom as a multimedia producer in 2023. Read more about Nicole. Every piece of reporting Nicole produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
